Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Understanding CAN/CSA C22.2 No. 60601-1-3-09 (R2014): Radiation Protection Requirements for Diagnostic X-Ray Equipment
Essential Safety and Performance Criteria for Medical X-Ray Systems in Canada
Scope and Application
CAN/CSA C22.2 No. 60601-1-3-09 (R2014) is the Canadian adoption of the international collateral standard IEC 60601-1-3:2008, titled Medical electrical equipment – Part 1-3: General requirements for basic safety and essential performance – Collateral standard: Radiation protection in diagnostic X-ray equipment. Developed under the Canadian Electrical Code umbrella (C22.2 series), this standard applies to medical electrical equipment intended for diagnostic X‑ray imaging, including radiographic, fluoroscopic, mammographic, and computed tomography systems. Its primary objective is to ensure that radiation protection features are integrated into the design, manufacture, and testing of such equipment, thereby safeguarding patients, operators, and the public.
Tip: CAN/CSA C22.2 No. 60601-1-3-09 is harmonized with IEC 60601-1-3:2008 and includes Canadian deviations where necessary to align with Health Canada requirements and the Canadian Electrical Code.
The standard covers the basic safety and essential performance aspects of radiation protection that are not addressed by the general standard IEC 60601‑1 (or its Canadian equivalent). It is mandatory for manufacturers seeking compliance under Canada’s Medical Devices Regulations and is frequently referenced by provincial regulators and accreditation bodies.
Key Technical Requirements
The collateral standard defines a set of technical requirements organized around the following core areas:
X-Ray Source Assembly
Requirements address the inherent and total filtration of the X‑ray beam, which influence beam quality and patient dose. The standard mandates minimum equivalent filtration (typically 2.5 mm Al for equipment operating above 70 kV) and requires that the half‑value layer (HVL) meet specified minima. Leakage radiation from the X‑ray source assembly must not exceed 1.0 mGy/h at a distance of 1 m from the focal spot when the tube is operated at its maximum rated conditions.
Beam Limitation and Indication
All equipment must provide a means to limit the useful X‑ray beam to the image receptor area. For equipment that allows field size adjustment, the deviation between the indicated and actual beam dimensions is strictly controlled (e.g., ±2 % of the source‑to‑image distance for general radiography). Automatic collimation systems must ensure the beam never exceeds the receptor area by more than 3 % of the SID. These requirements are essential to avoid unnecessary irradiation of tissues outside the region of interest.
Dose Indication and Control
Equipment that provides air kerma or dose‑area product (DAP) indications must meet accuracy criteria defined in the standard. For systems with automatic exposure control (AEC), the reproducibility and accuracy of the indicated dose are verified under reference conditions. The standard also specifies requirements for manual exposure control, including clear labelling of control settings and the presence of an audible or visual exposure termination indicator.
| Parameter | Requirement | Reference Clause |
|---|---|---|
| Total beam filtration (equipment ≥70 kV) | ≥ 2.5 mm Al equivalent | 201.8.1 |
| Leakage radiation (max. at 1 m) | ≤ 1.0 mGy/h | 201.9.1 |
| Beam field deviation (indicated vs. actual) | ±2 % of SID | 202.3.1 |
| Dose indication accuracy (air kerma or DAP) | ±35 % for reference conditions | 203.1.2 |
| Half‑value layer at 80 kV | ≥ 2.9 mm Al (for total filtration ≥2.5 mm Al) | 201.8.2 |
Implementation and Testing
Manufacturers must integrate these radiation protection requirements throughout the design‑control process. Compliance is demonstrated through type testing, design review, and routine production testing. The standard requires that a risk management process (per ISO 14971 or CAN/CSA‑ISO 14971) is applied to identify potential radiation hazards and to verify that residual risks are reduced to acceptable levels.
Warning: The standard explicitly prohibits the use of software alone to meet beam‑limitation or filtration requirements unless the software is validated in accordance with the quality‑management system and the risk management file demonstrates adequate control of failures.
Testing for certification typically involves measurement of filtration (HVL and equivalent), leakage radiation with the X‑ray tube shielded, and beam alignment/field size accuracy. Dose indication accuracy is verified using calibrated reference detectors under the conditions defined in the standard. Special attention must be paid to equipment intended for mammography or CT, where additional clauses (notably 201.10 for mammography and 201.11 for CT) impose more stringent limits on dose and beam quality.
Best Practice: Early involvement of an accredited testing laboratory (e.g., CSA, UL, or Intertek) during the design phase can significantly reduce the time and cost of certification. Pre‑compliance measurements help identify filtration or beam‑limitation issues before final submission.
Compliance and Certification Notes
In Canada, recognition of CAN/CSA C22.2 No. 60601-1-3-09 is often a prerequisite for Health Canada medical device licensing. Most major certification bodies issue a certificate of compliance that references this standard alongside the general standard CAN/CSA C22.2 No. 60601-1-08 (adoption of IEC 60601-1). Canadian deviations include additional markings (e.g., bilingual warnings) and alignment with the Canadian Electrical Code Part I for installation requirements.
It is important to note that the standard was reaffirmed in 2014 (R2014) and remains current as of 2026. However, IEC has published a 2022 edition of IEC 60601-1-3 (Edition 2.1). Manufacturers planning new product introductions should monitor the CSA adoption schedule for potential updates that may introduce stricter requirements (e.g., for pediatric patients and interventional fluoroscopy).
Critical: Non‑compliance with the beam‑limitation or dose‑indication requirements of this standard is considered a serious safety deficiency. In the event of a field failure, manufacturers must initiate corrective actions in accordance with Health Canada’s Medical Device Recall regulations and may need to revise their risk management files.
Frequently Asked Questions
Q: Does CAN/CSA C22.2 No. 60601-1-3-09 apply to dental X‑ray equipment?
A: Yes, the standard covers all diagnostic X‑ray equipment, including intraoral and panoramic dental systems. However, specific requirements for dental units may be found in the appropriate particular standards (e.g., IEC 60601‑2‑63 for extra‑oral dental systems). The collateral standard still applies for filtration, leakage, and general radiation protection aspects.
A: Yes, the standard covers all diagnostic X‑ray equipment, including intraoral and panoramic dental systems. However, specific requirements for dental units may be found in the appropriate particular standards (e.g., IEC 60601‑2‑63 for extra‑oral dental systems). The collateral standard still applies for filtration, leakage, and general radiation protection aspects.
Q: What is the relationship between this CSA standard and the original IEC 60601-1-3?
A: CAN/CSA C22.2 No. 60601-1-3-09 is essentially the IEC text with Canadian national deviations. The deviations are listed in a separate annex and include adjustments to reflect Canadian regulatory requirements (e.g., bilingual labelling) and references to the Canadian Electrical Code. For global manufacturers, meeting the IEC edition plus the CSA deviations is necessary for the Canadian market.
A: CAN/CSA C22.2 No. 60601-1-3-09 is essentially the IEC text with Canadian national deviations. The deviations are listed in a separate annex and include adjustments to reflect Canadian regulatory requirements (e.g., bilingual labelling) and references to the Canadian Electrical Code. For global manufacturers, meeting the IEC edition plus the CSA deviations is necessary for the Canadian market.
Q: How often does the standard require recertification or retesting?
A: The standard itself does not mandate a specific recertification interval. However, medical device manufacturers are expected to maintain compliance as part of their quality management system (ISO 13485). Any significant design change or a new model should undergo a fresh conformity assessment. The certificate of compliance may have a validity period (typically 5 years) as determined by the certifying body.
A: The standard itself does not mandate a specific recertification interval. However, medical device manufacturers are expected to maintain compliance as part of their quality management system (ISO 13485). Any significant design change or a new model should undergo a fresh conformity assessment. The certificate of compliance may have a validity period (typically 5 years) as determined by the certifying body.
Q: Are there special provisions for pediatric patients?
A: The 2008 edition of IEC 60601‑1‑3 (the basis for CSA C22.2 No. 60601-1-3-09) introduced specific requirements for equipment used with pediatric patients. These include lower dose‑indication thresholds and enhanced beam‑limitation controls. Manufacturers must demonstrate that the equipment can be configured appropriately for pediatric use, as defined in the accompanying risk management documentation.
A: The 2008 edition of IEC 60601‑1‑3 (the basis for CSA C22.2 No. 60601-1-3-09) introduced specific requirements for equipment used with pediatric patients. These include lower dose‑indication thresholds and enhanced beam‑limitation controls. Manufacturers must demonstrate that the equipment can be configured appropriately for pediatric use, as defined in the accompanying risk management documentation.